Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Central and South America 12 Clinical Trials by G7 Countries: Proportion of Pandemic Influenza to Infectious Disease Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Pandemic Influenza to Infectious Disease Clinical Trials 16 Clinical Trials by Phase in E7 Countries 17 Clinical Trials in E7 Countries by Trial Status 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Clinical Trials by End Point Status 22 Subjects Recruited Over a Period of Time 23 Clinical Trials by Sponsor Type 24 Prominent Sponsors 25 Top Companies Participating in Pandemic Influenza Therapeutics Clinical Trials 26 Prominent Drugs 27 Clinical Trial Profile Snapshots 28 Appendix 89 Abbreviations 89 Definitions 89 Research Methodology 90 Secondary Research 90 About GlobalData 91 Contact Us 91 Disclaimer 91 Source 92

List of Tables Pandemic Influenza Therapeutics, Global, Clinical Trials by Region, 2016* 6 Pandemic Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Pandemic Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Pandemic Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Pandemic Influenza Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Pandemic Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 12 Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13 Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16 Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Pandemic Influenza Therapeutics, Global, Clinical Trials by Phase, 2016* 19 Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20 Pandemic Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Pandemic Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Pandemic Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Pandemic Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24 Pandemic Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Pandemic Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Pandemic Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 List of Figures Pandemic Influenza Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Pandemic Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Pandemic Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Pandemic Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Pandemic Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Pandemic Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 12 Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13 Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16 Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Pandemic Influenza Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19 Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20 Pandemic Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Pandemic Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Pandemic Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Pandemic Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24 Pandemic Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Pandemic Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Pandemic Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 GlobalData Methodology 90

Novartis AG GlaxoSmithKline Plc AstraZeneca Plc Sanofi Novavax, Inc. CSL Limited Microgen Scientific Industrial Company for Immunobiological Medicines Johnson & Johnson Nanotherapeutics, Inc. Accelovance Inc.